Invention Grant
US08795656B2 Methods of treating rheumatoid arthritis by administering an anti-IL3 antibody
有权
通过施用抗IL3抗体治疗类风湿性关节炎的方法
- Patent Title: Methods of treating rheumatoid arthritis by administering an anti-IL3 antibody
- Patent Title (中): 通过施用抗IL3抗体治疗类风湿性关节炎的方法
-
Application No.: US13132754Application Date: 2009-12-04
-
Publication No.: US08795656B2Publication Date: 2014-08-05
- Inventor: Matthias Mack , Hilke Brühl
- Applicant: Matthias Mack , Hilke Brühl
- Applicant Address: DE Regensburg
- Assignee: Klinikum der Universitat Regensburg
- Current Assignee: Klinikum der Universitat Regensburg
- Current Assignee Address: DE Regensburg
- Agency: Kagan Binder, PLLC
- Priority: EP08021114 20081204
- International Application: PCT/EP2009/008703 WO 20091204
- International Announcement: WO2010/063488 WO 20100610
- Main IPC: A61K39/395
- IPC: A61K39/395 ; A61K38/00 ; A61K39/00
Abstract:
The use of an IL-3 inhibitor for prophylactic treatment of rheumatoid arthritis, for treatment of rheumatoid arthritis in an early stage, during early phases of exacerbation, or as maintenance therapy to prevent disease flares or disease progression in a subject is described.
Public/Granted literature
- US20120039872A1 IL-3 INHIBITORS IN USE FOR TREATMENT OF RHEUMATOID ARTHRITIS IN AN EARLY STAGE Public/Granted day:2012-02-16
Information query
